PREPAYMENTS AND OTHER CURRENT ASSETS (Schedule of Prepayments and Other Current Assets) (Details)
¥ in Thousands, $ in Thousands
Dec. 31, 2017
CNY (¥)
Dec. 31, 2017
USD ($)
Dec. 31, 2016
CNY (¥)
Prepaid Expenses And Other Current Assets [Line Items]      
Prepayments to ZR Guofu [1] ¥ 0 $ 0 ¥ 53,141
Due from suppliers [2] 23,243 3,572 11,148
Due from hospitals [3] 1,179 181 21,274
Loan receivables [4] 114,456 17,592 43,503
Advances to employees [5] 4,383 674 6,354
Receivables from disposal of medical equipment [6] 90,324 13,883 12,668
Deferred expenses 111 17 1,637
Interest receivable 5,100 784 9,571
Dividend receivable 766 118 766
Others 29,959 4,603 6,548
Prepayments and other current assets, gross 269,521 41,424 166,610
Reserve for unrecoverable deposits (4,798) (737) (4,798)
Prepayments and other current assets ¥ 264,723 $ 40,687 ¥ 161,812
[1] Prepayments to ZR Guofu represented the prepayment made for the annual interest expense and consultation expense as of December 31, 2016 (note 1).
[2] Amounts due from suppliers represent prepayments made for orders and returnable deposits of cancelled orders. The risk of loss arising from non-performance by or bankruptcy of suppliers is assessed prior to the order of the equipment. The Group has provided reserve amounting to RMB4,798 and RMB4,798 (US$737) on amounts due from suppliers as at December 31, 2016 and 2017, respectively.
[3] Amounts due from hospitals represent interest-free advances to hospitals and the compensation to be received from hospitals for early termination. The Group has assessed the impact of such advances on revenue recognition at the outset of the arrangement and has concluded that they do not affect revenue recognition. The risk of loss arising from any failure of hospital customers to fulfill their financial obligations is assessed prior to making the advances and is monitored for recoverability on a regular basis by management.
[4] Loan receivables represented the loans to others parties, including loans to related parties such as the Xi’an JiangyuanAndike Ltd. (“JYADK”), Allcure Information of total amount of RMB13,658 and RMB13,658 (US$1,967) as at December 31, 2016 and 2017, respectively. Besides, the loan to JYADK contributed to interest receivable of RMB370 (US$53) and RMB221 (US$34) as at December 31, 2016 and 2017, respectively (note 24).
[5] The advances to employees represent interest-free advance held by the Company’s employees to cover expenses of hospital customers. The risk of loss is assessed prior to making the advances and is monitored on a regular basis by management. Historically, the Group has not experienced any loss of such advances.
[6] Receivables from disposal of medical equipment represented the consideration to be received from several hospitals, which the Group entered into termination contracts with and disposed all leasing equipment to.